Results 181 to 190 of about 4,325,962 (256)

Acute Adenosine Receptor Antagonism in Combination With Acute Intermittent Hypoxia to Promote Breathing Plasticity in Amyotrophic Lateral Sclerosis: Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial. [PDF]

JMIR Res Protoc
Sales de Campos P, Smith-Hublou M, Olsen WL, Souza Leite W, Wymer JP, Napoli NJ, Vose AK, Pulley MT, Mitchell GS, Smith BK.   +9 more
europepmc   +1 more source

Reduced adenosine receptor expression in ACS patients with no-reflow phenomenon undergoing primary PCI. [PDF]

Future Cardiol
Bagheri A, Alipour Parsa S, Namazi MH, Khaheshi I, Sohrabifar N.   +4 more
europepmc   +1 more source

Cantharidin attenuates the anti-β-adrenergic or anti-histaminergic or anti-serotoninergic effect of A₁-adenosine receptor stimulation in the isolated human atrium. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Schwarz R, Hofmann B, Kirchhefer U, Neumann J, Gergs U.   +4 more
europepmc   +1 more source

Synthesis and Biological Evaluation of 5'-Deoxy-adenosine Derivatives as A₃ Adenosine Receptor Ligands. [PDF]

ACS Med Chem Lett
Kim M, Naik SD, Choi H, Kim SW, Park JH, Joung M, Song J, Gaikwad VB, Kim M, Jeong LS.   +9 more
europepmc   +1 more source

Impact of the adenosine receptor A2BR expressed on myeloid cells on immune regulation during pregnancy. [PDF]

Eur J Immunol
Dietz S, Hebel J, Rühle J, Huff A, Eltzschig HK, Lajqi T, Poets CF, Gille C, Köstlin-Gille N.   +8 more
europepmc   +1 more source

Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists. [PDF]

Molecules
Laversin A, Dufossez R, Bolteau R, Duroux R, Ravez S, Hernandez-Tapia S, Fossart M, Coevoet M, Liberelle M, Yous S, Lebègue N, Melnyk P.   +11 more
europepmc   +1 more source

Structure-Activity Relationship Analysis of 2-Aryl-8-alkynyl Adenine and Nucleoside Scaffolds as A₃ Adenosine Receptor Ligands. [PDF]

ACS Med Chem Lett
Kim G, Lee G, Jarhad DB, Gao ZG, Kim SW, Joung M, Jacobson KA, Jeong LS.   +7 more
europepmc   +1 more source

Cryo-EM structures of adenosine receptor A₃AR bound to selective agonists. [PDF]

Nat Commun
Cai H, Guo S, Xu Y, Sun J, Li J, Xia Z, Jiang Y, Xie X, Xu HE.   +8 more
europepmc   +1 more source

Therapeutic exploration potential of adenosine receptor antagonists through pharmacophore ligand-based modelling and pharmacokinetics studies against Parkinson disease. [PDF]

In Silico Pharmacol
Ajala A, Asipita OH, Michael AT, Tajudeen MT, Abdulganiyyu IA, Ramu R.   +5 more
europepmc   +1 more source